ÂÜÀòÂÒÂ×

As Professor and Chief of Scientific Intelligence at the John Wayne Cancer Institute, Dr. Hoon has unparalleled experience in the translational research of innovative technologies. As one of world's leading experts on circulating cfDNA, he provides the Biological Dynamics team with guidance in their pursuit of meaningful clinical applications of ACE technology.

He has coauthored more than 330 peer-reviewed articles and reviews, primarily related to the translational molecular oncology of human solid tumors, and has over 25 patents on his studies. As Founding Director of the Department of Molecular Oncology, Dr. Hoon continues to pioneer investigations of RNA/genomic/epigenomic biomarkers for diagnostic, prognostic, and predictive assessment of residual tumor cells. Dr. Hoon spearheads investigations of circulating DNA/miRNA biomarkers for staging cancer and classification of solid tumors, including melanoma, breast cancer, gastrointestinal cancer and primary brain tumors.